Mammoth Scientific, a health science and technology venture capital firm, has selected SS&C as administrator and technology partner for its inaugural USD100 million fund.
The fund will provide venture capital to health science and technology companies maturing beyond seed rounds.
The venture capital firm is building a proprietary platform to enable registered investment advisors to access venture capital investments for their retail clients. As a result, they needed a partner to provide proven independent fund administration for their new funds plus technology to support their retail client strategy. After evaluating multiple vendors, Mammoth Scientific chose SS&C’s private markets solution, including end-to-end fund administration with InvestorVision, SS&C’s investor reporting portal technology.
“We selected SS&C as a technology partner for the launch of our inaugural fund because of its extensive experience in private markets and its ability to deliver innovative solutions to power our vision,” says Jud Mackrill, Chief Experience Officer, Mammoth Scientific. “We wanted to democratize the early-stage alternative investment access and needed a bespoke solution to support the backbone of our operations. SS&C has the know-how and the breadth of technology to support us.”
“We are pleased to partner with Mammoth Scientific in the launch of their innovative inaugural VC fund,” says Bhagesh Malde, General Manager of SS&C GlobeOp Private Markets. “Mammoth is paving the way for accredited retail investors to access new alternative investment opportunities with their innovative platform. In addition, SS&C’s private markets offering enables start-ups, such as Mammoth, to go to market and enable integrated operations quickly.”
